Dexmedetomidine as an adjuvant to local anesthetics in ophthalmic surgery

Abstract

Vitreoretinal surgery aims to restore the structural relationships of the posterior segment of the eye, with the possibility of partial or complete restoration of visual functions, and imposes certain requirements to the anesthetic support of operations. These are injuries, operations length, age, and concomitant pathology of organs and systems of patients. In this regard, there is a recent tendency to use different pharmacological groups as adjuvants to local anesthetics to enhance or prolong their analgesic effect. Purpose to evaluate the effectiveness of dexmedetomidine as an adjuvant in retrobulbar blockades. Materials and methods. Retrobulbar block bupivacaine with dexmedetomidine at a dose of 0.25 mg/kg was performe in the 1st group (n = 22), retrobulbar block was performed with a mixture of bupivacaine in the 2nd group (n = 22). Changes in hemodynamics at the stages of surgery were evaluated. To assess the oxidative status, the evaluation of the redox coefficient (FORT/FORD) was conducted before and after the surgery. The level of comfort of the operation by the surgeon and the patient. Assessment of pain was performed by a VRS in the points. Results. In patients of the 1st group the decrease in SAD was more pronounced and persisted throughout the entire period of surgical treatment. 54.5% of patients of group 1 and 18% of group 2 had no pain 8 hours after the surgery. 82% of patients of group 2 reported moderate pain that required medication (p < 0,05). In patients of group 1, it increased from 0.45 ± 0.5 to 0.62 ± 0.2 (p < 0,005) by 37% of the initial value, in patients of group 2, it was shown to decrease by 5% (p > 0,05). In group 1, the comfort of the operation was estimated by ophthalmic surgeons as «satisfactory» in 77.3%, and in group 2 in 54.5% (p < 0,05). Conclusion. The use of dexmedetomidine as an adjuvant of local anesthetics in ophthalmic surgery provides the necessary analgesia, hemodynamic profile of the patient, antioxidant effect and affects the quality of the surgeon’s work, which affects the duration of operations.

Keywords

dexmedetomidine / retrobulbar block / vitreous detachment / vitrectomy

References

[1] Avetisov S.E. Ophthalmology. National guidelines. [Ophtal’ mologiya. Natsional’noe rukovodstvo]. Moscow: GEOTAR-Media, 2008.S.17-26. (in Russ.)

[2] Аветисов С.Э. Офтальмология. Национальное руководство. М.: ГЭОТАР-Медиа, 2008. С. 17-26.

[3] Brinton D.A., Wilkinson C.P. Retinal detachment – Principles and practice. Oxford: University Press. Inc. 2009:109-6.

[4] Öhman Т., Tamene F., Göös Н. Systems pathology analysis identifies neurodegenerative nature of age-related vitreoretinal interface diseases. Aging Cell. 2018;17(5):1-16

[5] Öhman. Т., Tamene. F., Göös. Н. Systems pathology analysis identifies neurodegenerative nature of age-related vitreoretinal interface diseases. Aging Cell. 2018;17(5):1-16.

[6] Osawa S., Oshima Y. 27-Gauge vitrectomy. Dev. Ophthalmol. 2014;54:54-62.

[7] Marzak S., Miloudi Y., El Harrar N., Bensaid A., Zaghloul K., Amraoui A. Postoperative pain in retinal detachment surgery. J. Fr. Ophtalmol. 2007;30(10):992-7. (in French).

[8] Marzak S., Miloudi Y., El Harrar N., Bensaid A., Zaghloul K., Amraoui A. Postoperative pain in retinal detachment surgery. J. Fr. Ophtalmol. 2007;30(10):992-7. (in French)

[9] Marova N.G., Vasiliev I.I., Klyushnikova E.V., Kononov A.V., Polyakova T.S. Local anesthesia for vitreoretinal operations. Regionarnaya anesteziya i lechenie ostroy boli. 2018;12(1):24-9. (in Russ.)

[10] Марова Н.Г., Васильев Я.И., Клюшникова Е.В., Кононов А.В., Полякова Т.С. Местная анестезия при витреоретинальных операциях. Регионарная анестезия и лечение острой боли. 2018;12(1):24-9.

[11] Suresh S., Ecoffey C., Bosenberg A. et al. The European Society of Regional Anesthesia and Pain Therapy / American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Reg. Anesth. Pain Med. 2018; 43(2):211-6.

[12] Suresh S., Ecoffey C., Bosenberg A. et al. The European Society of Regional Anaesthesia and Pain Therapy. American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Reg. Anesth. Pain Med. 2018; 43(2):211-6.

[13] Abdallah F., Dwyer T., Chan V. et al. IV and perineural dex-medetomidine similarly prolong the duration of analgesia after interscalene brachial plexus block: a randomized, three-arm, triple-masked, placebocontrolled trial. Anesthesiology. 2016; 124(3):683-95.

[14] Oleshenko I.G., Kuzmin S.V., Gasparyan M.A. Anesthesia method for vitreoretinal and episcleral surgery. Patent RF No. 2713133; 2018. (in Russ.)

[15] Олещенко И.Г., Кузьмин С.В., Гаспарян М.А. Способ обезболивания при витреоретинальной и эписклеральной хирургии. Патент на изобретение РФ № 2713133, 2018.

[16] Gagliese L., Weizblit N., Ellis W., Chan V.W.S. The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients. Pain. 2005;117(3):412-420.

[17] Gagliese L., Weizblit N., Ellis W., Chan V.W.S., The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients. Pain. 2005;117(3): 412-20.

[18] Oleshenko I.G., Zabolotsky D.V., Yuryeva T.N., Gasparyan M.A., Kursakova Yu.V. The influence of pterygopalatine blockade on the change in redox potential in the surgical treatment of congenital cataract. Sibirskiy nauchny meditsinskiy zhurnal. 2018; 38(5):72-8. (in Russ.)

[19] Олещенко И.Г., Заболотский Д.В., Юрьева Т.Н., Гаспа- рян М.А., Курсакова Ю.В. Влияние крылонёбной блокады на изменение окислительно-восстановительного потенциала при хирургическом лечении врождённой катаракты. Сибирский научный медицинский журнал. 2018;38(5):72-78.

[20] Oleshenko I.G., Yuryeva T.N., Zabolotsky D.V., Gorbachev V.I. Blockade of the pterygopalatine node as a component of combined anesthesia during surgical intervention for congenital cataracts of the eye in children. Regionarnaya anesteziya i lechenie ostroy boli. 2017;11(3):202-7. (in Russ.)

[21] Олещенко И.Г., Юрьева Т.Н., Заболотский Д.В., Горба- чев В.И. Блокада крылонёбного узла как компонент сочетанной анестезии при оперативном вмешательстве по поводу врожденной катаракты глаза у детей. Регионарная анестезия и лечение острой боли. 2017;11(3):202-7.

[22] Zabolotsky D.V., Koryachkin V.A., Savenkov A.N., Felker E.Yu., Lavrenchuk A.V. The effect of dexamethasone on the quality of the analgesic effect of peripheral blockade. Regionarnaya anesteziya i lechenie ostroy boli. 2017;11(2):84-9. (in Russ.)

[23] Заболотский Д.В., Корячкин В.А., Савенков А.Н., Фель- кер Е.Ю., Лавренчук А.В. Влияние дексаметазона на качество анальгетического эффекта перифериферических блокад. Регионарная анестезия и лечение острой боли. 2017; 11(2):84-9.

[24] Grosu I., Lavand’homme P. Use of dexmedetomidine for pain control. F1000 Med. Rep. 2010;2:90.

[25] Arefyev A.M., Kulikov A.S., Lubnin A.Yu. Dexmedetomidine in neuroanesthesiology. Anesteziologiya i reanimatiologiya. 2017;62(3):213-9. (in Russ.)

[26] Арефьев А.М., Куликов А.С., Лубнин А.Ю. Дексмедетомидин в нейроанестезиологии. Анестезиология и реаниматология. 2017;62(3):213-9.

[27] Lukovskaya N.G., Astakhov Yu.S., Saigina E.A. Analysis of the frequency and causes of relapse of retinal detachment after the external stages of surgical treatment. Ophthal’mologicheskie vedomosti. 2010;3(4):24-8. (in Russ.)

[28] Луковская Н. Г., Астахов Ю. С., Сайгина Е.А. Анализ частоты и причин развития рецидивов отслойки сетчатки после наружных этапов оперативного лечения. Офтальмологические ведомости. 2010;3(4):24-8.

[29] Ovechkin A.M., Politov M.E., Bulanova E.L. Dexmedetomidine as a component of anesthesia and a promising basis for non-opioid analgesia regimens. Regionarnaya anesteziya i lechenie ostroy boli. 2018;12(2):82-90. (in Russ.)

[30] Овечкин А.М., Политов М.Е., Буланова Е.Л. Дексмедетомидин как компонент анестезии и перспективная основа схем безопиоидной анальгезии. Регионарная анестезия и лечение острой боли. 2018;12(2):82-90.

RIGHTS & PERMISSIONS

Eco-Vector